BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Peoples Bancorp
PEBO
$1.48B
| $31.1M | ﹤0.01% |
1,462,613
+18,643
| +1% | +$408K |
|
2552
Dime Commercial Bancshares
DCOM
$1.82B
| $31.1M | ﹤0.01% |
1,362,136
+138,848
| +11% | +$2.85M |
|
2553
Castle Biosciences
CSTL
$980M
| $31M | ﹤0.01% |
821,977
+106,782
| +15% | +$3.65M |
|
|
NPKI
2554
NPK International
NPKI
$1.19B
| $31M | ﹤0.01% |
13,891,264
-299,816
| -2% | -$508K |
|
2555
Crinetics Pharmaceuticals
CRNX
$8.96B
| $31M | ﹤0.01% |
1,767,869
+1,045,566
| +145% | +$17.8M |
|
2556
Puma Biotechnology
PBYI
$456M
| $30.8M | ﹤0.01% |
2,956,296
+140,413
| +5% | +$1.45M |
|
2557
PAR Technology
PAR
$725M
| $30.8M | ﹤0.01% |
1,029,909
+268,839
| +35% | +$5.88M |
|
2558
Liberty Latin America Class A
LILA
$1.7B
| $30.8M | ﹤0.01% |
4,952,013
-123,997
| -2% | -$814K |
|
2559
Shinhan Financial Group
SHG
$34.5B
| $30.7M | ﹤0.01% |
1,274,985
+1,111,188
| +678% | +$27.2M |
|
2560
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
| $30.6M | ﹤0.01% |
195,610
-11,403
| -6% | -$1.68M |
|
2561
i3 Verticals
IIIV
$315M
| $30.6M | ﹤0.01% |
1,011,245
+26,205
| +3% | +$665K |
|
2562
Conduent
CNDT
$241M
| $30.5M | ﹤0.01% |
12,774,515
+164,293
| +1% | +$382K |
|
2563
Kiniksa Pharmaceuticals
KNSA
$6.05B
| $30.5M | ﹤0.01% |
1,196,820
+263,807
| +28% | +$5.51M |
|
2564
Tucows
TCX
$144M
| $30.4M | ﹤0.01% |
531,045
+16,600
| +3% | +$922K |
|
2565
Grupo Aeroportuario Centro Norte
OMAB
$5.25B
| $30.4M | ﹤0.01% |
819,143
-163,361
| -17% | -$5.27M |
|
2566
Regis Corp
RGS
$70.3M
| $30.3M | ﹤0.01% |
185,402
-6,352
| -3% | -$1.19M |
|
2567
Arlo Technologies
ARLO
$1.52B
| $30.3M | ﹤0.01% |
11,737,541
+211,736
| +2% | +$511K |
|
|
AGNT
2568
AGNT Inc
AGNT
$704M
| $30.2M | ﹤0.01% |
3,548,134
+116,942
| +3% | +$599K |
|
|
CUTR
2569
DELISTED
Cutera, Inc.
CUTR
| $30.2M | ﹤0.01% |
2,484,879
+399,879
| +19% | +$5.27M |
|
2570
Ocular Therapeutix
OCUL
$2.27B
| $30.1M | ﹤0.01% |
3,617,625
+756,696
| +26% | +$5.02M |
|
2571
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $30.1M | ﹤0.01% |
1,267,885
+1,267,883
| +63,394,150% | +$29.2M |
|
2572
Barrett Business Services
BBSI
$751M
| $30.1M | ﹤0.01% |
2,264,112
+119,992
| +6% | +$1.39M |
|
2573
Replimune Group
REPL
$1.27B
| $30.1M | ﹤0.01% |
1,209,476
+168,641
| +16% | +$2.98M |
|
|
APLT
2574
DELISTED
Applied Therapeutics
APLT
| $30M | ﹤0.01% |
831,082
+299,727
| +56% | +$12.5M |
|
2575
Heritage Insurance Holdings
HRTG
$979M
| $30M | ﹤0.01% |
2,294,556
-31,704
| -1% | -$371K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.